
Dr. Lawrence Chan is the Betty Rutherford Chair for Diabetes Research and and the Director of the NIH-funded Diabetes & Endocrinology Research Center at Baylor College of Medicine. He is also the director of the Molecular Medicine Scholars Program and a professor in the departments of Medicine and Molecular and Cellular Biology...



Dr. Kulkarni is a Principal Investigator at the Joslin Diabetes Center, Assistant Professor of Medicine and a Faculty Member of the BBS Graduate Program at Harvard Medical School. Dr Kulkarni graduated with MD and PhD degrees from St. John's Medical College and the Royal Postgraduate Medical School, University of London, England. While working o..



Dr. Ingolf Bach’s interest in the molecular mechanisms has taken him from Paris, France where he received his PhD from the Pasteur Institute, to California for post-doctoral work, and back to his native Germany as a an Assistant Professor and Heisenberg Scholar at the Center for Molecular Neurobiology at the University of Hamburg. To..



Dr. Yong-Xu Wang came to the Program in Gene Function and Expression and the Program of Molecular..



His 39 page curriculum vitae would be the first indication that William H. Herman, M.D., M.P.H., is dedicated to his work. The proof lies in his many achievements as an internationally recognized researcher, educator, and clinician in the prevention and treatment of diabetes. Herman serves as the Director of the Michigan Diabetes Research and Tr..



Dr. Brian Lewis is a faculty member in the Program for Gene Expression and Function and the Program for Molecular Medicine here at UMass Medical School. His primary research interest is in molecular oncology; however,..



Dr. Piette is a Professor of Internal Medicine at the University of Michigan and a senior research associate at the Ann Arbor VA Center for Practice Management and Outcomes Research. He has conducted a number of multi-site diabetes randomized trials focusing on the use of interactive health technology to support ongoing monitoring and patient ed..



Dr. Martin Myers, U-M's Associate Professor of Internal Medicine and Associate Professor of Molecular and Integrative Physiology, conducts innovative research on insulin resistance. For the 15 million Americans who have diabetes, treating insulin resistance would extend and dramatically improve their lives.
Dr. Myers has personal as well..



As a graduate student in evolutionary biology, Dr. Philip DiIorio studied the genetics of fish adaptation Sonoran guppies. During his post-doctoral work in the Department of Endocrinology at New England Medical Center in Boston and subsequently in the Diabetes Division here at UMass Medical School he developed his interests in the genetic mecha..



Dr. Bell is the Louis Block Distinguished Service Professor in Medicine and Human Genetics. His research focuses on the molecular biology and genetics of diabetes. Dr. Bell is a member of the Institute of Medicine of the National Academy of Sciences and the American Academy of Arts and Sciences...



Amy Wagers, Ph.D., who is emerging as a leading researcher in stem cell biology, exemplifies the value of providing support at that critical juncture in a young scientist’s career. In 2004, she became an assistant professor of pathology at Harvard Medical School, a principal investigator in the Section on Developmental and ..



Charles F. Burant, M.D., Ph.D. is the Dr. Robert C. and Veronica Atkins professor of Metabolism. Dr. Burant received his bachelor's degree from the University of Wisconsin and his graduate and medical degrees from the Medical University of South Carolina in Charleston. He completed his residency training at the University of California, San Fr..


The NIDDK-supported Diabetes Endocrinology Research Centers (DERCs) and Diabetes Research and Training Centers (DRTCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DERCs and DRTCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. Both DERCs and DRTCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.